Literature DB >> 21195311

Natural and expanded CD4(+)CD25(+) regulatory T cells in bone marrow transplantation.

Lucrezia Colonna1, Emanuela I Sega, Robert S Negrin.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21195311      PMCID： PMC3053046          DOI： 10.1016/j.bbmt.2010.10.020

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN： 1083-8791            Impact factor:   5.742


× No keyword cloud information.
  55 in total

Review 1.  Regulatory T cells in transplantation tolerance.

Authors:  Kathryn J Wood; Shimon Sakaguchi
Journal:  Nat Rev Immunol       Date:  2003-03       Impact factor: 53.106

2.  Control of regulatory T cell development by the transcription factor Foxp3.

Authors:  Shohei Hori; Takashi Nomura; Shimon Sakaguchi
Journal:  Science       Date:  2003-01-09       Impact factor: 47.728

3.  Cutting edge: CD28 controls peripheral homeostasis of CD4+CD25+ regulatory T cells.

Authors:  Qizhi Tang; Kammi J Henriksen; Elisa K Boden; Aaron J Tooley; Jianqin Ye; Sumit K Subudhi; Xin X Zheng; Terry B Strom; Jeffrey A Bluestone
Journal:  J Immunol       Date:  2003-10-01       Impact factor: 5.422

4.  The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality.

Authors:  Patricia A Taylor; Christopher J Lees; Bruce R Blazar
Journal:  Blood       Date:  2002-05-15       Impact factor: 22.113

5.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.

Authors:  Jason D Fontenot; Marc A Gavin; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

6.  Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD425 T cells to allow an effective graft-versus-leukemia response.

Authors:  Stephen C Jones; George F Murphy; Robert Korngold
Journal:  Biol Blood Marrow Transplant       Date:  2003-04       Impact factor: 5.742

7.  Induction of allopeptide-specific human CD4+CD25+ regulatory T cells ex vivo.

Authors:  Shuiping Jiang; Niels Camara; Giovanna Lombardi; Robert I Lechler
Journal:  Blood       Date:  2003-05-29       Impact factor: 22.113

8.  CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation.

Authors:  Matthias Edinger; Petra Hoffmann; Joerg Ermann; Kathryn Drago; C Garrison Fathman; Samuel Strober; Robert S Negrin
Journal:  Nat Med       Date:  2003-08-17       Impact factor: 53.440

9.  Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function.

Authors:  M K Levings; R Sangregorio; M G Roncarolo
Journal:  J Exp Med       Date:  2001-06-04       Impact factor: 14.307

10.  CD4(+)CD25(+) immunoregulatory T Cells: new therapeutics for graft-versus-host disease.

Authors:  José L Cohen; Aurélie Trenado; Douglas Vasey; David Klatzmann; Benoît L Salomon
Journal:  J Exp Med       Date:  2002-08-05       Impact factor: 14.307
View more
  9 in total

1.  T regulatory cell mediated immunotherapy for solid organ transplantation: A clinical perspective.

Authors:  Mohammad Afzal Khan
Journal:  Mol Med       Date:  2016-11-22       Impact factor: 6.354

2.  Donor Requirements for Regulatory T Cell Suppression of Murine Graft-versus-Host Disease.

Authors:  Antonio Pierini; Lucrezia Colonna; Maite Alvarez; Dominik Schneidawind; Hidekazu Nishikii; Jeanette Baker; Yuqiong Pan; Mareike Florek; Byung-Su Kim; Robert S Negrin
Journal:  J Immunol       Date:  2015-05-20       Impact factor: 5.422

Review 3.  Thinking out of the box--new approaches to controlling GVHD.

Authors:  Frédéric Baron; Stéphanie Humblet-Baron; Grégory Ehx; Sophie Servais; Muriel Hannon; Ludovic Belle; Chantal Lechanteur; Alexandra Briquet; Olivier Giet; Etienne Baudoux; Evelyne Willems; Yves Beguin
Journal:  Curr Hematol Malig Rep       Date:  2014-03       Impact factor: 3.952

Review 4.  Mesenchymal stromal cells: a new tool against graft-versus-host disease?

Authors:  Frédéric Baron; Rainer Storb
Journal:  Biol Blood Marrow Transplant       Date:  2011-09-29       Impact factor: 5.742

5.  Engraftment of embryonic stem cells and differentiated progeny by host conditioning with total lymphoid irradiation and regulatory T cells.

Authors:  Yuqiong Pan; Dennis B Leveson-Gower; Patricia E de Almeida; Antonio Pierini; Jeanette Baker; Mareike Florek; Hidekazu Nishikii; Byung-Su Kim; Rong Ke; Joseph C Wu; Robert S Negrin
Journal:  Cell Rep       Date:  2015-03-24       Impact factor: 9.423

6.  Post-transplant bendamustine reduces GvHD while preserving GvL in experimental haploidentical bone marrow transplantation.

Authors:  Jessica Stokes; Emely A Hoffman; Yi Zeng; Nicolas Larmonier; Emmanuel Katsanis
Journal:  Br J Haematol       Date:  2016-03-31       Impact factor: 6.998

7.  C5a Blockade Increases Regulatory T Cell Numbers and Protects Against Microvascular Loss and Epithelial Damage in Mouse Airway Allografts.

Authors:  Mohammad Afzal Khan; Fatimah Alanazi; Hala Abdalrahman Ahmed; Axel Vater; Abdullah Mohammed Assiri; Dieter Clemens Broering
Journal:  Front Immunol       Date:  2018-05-24       Impact factor: 7.561

8.  Innate Immune Determinants of Graft-Versus-Host Disease and Bidirectional Immune Tolerance in Allogeneic Transplantation.

Authors:  Anouk A J Hamers; Sunil K Joshi; Asha B Pillai
Journal:  OBM Transplant       Date:  2019-01-31

9.  Role of lymphocyte activation gene-3 (Lag-3) in conventional and regulatory T cell function in allogeneic transplantation.

Authors:  Emanuela I Sega; Dennis B Leveson-Gower; Mareike Florek; Dominik Schneidawind; Richard H Luong; Robert S Negrin
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.